Introduction
In acute lymphoblastic leukemia (ALL), several genetic abnormalities associated with leukemogenesis have been reported (Look, 1997) . In adult ALL of B cell lineage, t(9;22)(q32;q11) resulting in the generation of an oncogenic fusion gene, BCR -ABL, is most frequently detected. In addition to BCR -ABL, ETV6 -AML1, E2A -Pbx, IgH -IL3, E2A -HLF and rearrangements involving the MLL gene are detected in ALL of B-cell lineage (Look, 1997; Willis and Dyer, 2000) . However, many oncogenes involved in translocations in ALL remain to be analysed.
In human cancer cells, oncogenes are frequently overexpessed by transcriptional deregulation (Lengauer et al., 1998; Nowell, 1997; Popescu and Zimonjic, 1997) . Gene amplification of oncogenes induces overexpression. This amplification is usually detected as double minutes or homogeneously stained regions on karyotyping (DeVita et al., 2001) . Translocation also results in the overexpression of oncogenes, in which the regulatory region of the oncogenes is replaced by the regulatory region, including enhancer elements, of other genes (Willis and Dyer, 2000) . In hematological malignancies derived from B lymphocytes, rearrangements between the immunoglobulin heavy chain (IgH) gene, which resides on chromosome 14q32, and oncogenes are frequently detected (Willis and Dyer, 2000) . In these rearrangements, the regulatory region of the oncogenes is replaced by the enhancer region of the IgH gene, which induces overexpression of the oncogene and is associated with tumorigenesis of the B cell lymphoid malignancies (Willis and Dyer, 2000) . is frequently detected in ALL of B-cell lineage (Mitelman et al., 1997) . Similarly, lymphomas and myelogenous malignancies often have genetic abnormalities involving this region (Mitelman et al., 1997) . 1q21-25 is one of the hotspots, areas of chromosomal alteration including duplications and translocations, frequently detected in hematological malignancies (Mitelman et al., 1997) . Although it is not clear whether duplications result in the gene amplification at present, this structural change in chromosomes might deregulate the expression pattern of the genes. Novel oncogene(s) might reside in this region and overexpression of the gene(s) might be associated with leukemogenesis.
T(1;14)(q25,q32) is a novel chromosomal abnormality detected in ALL of B-cell lineage. This translocation might involve the IgH gene and novel genes. Overexpression of a novel gene residing on 1q25 and fusion to the IgH gene could be associated with leukemogenesis.
In this study we cloned a junctional sequence of t(1;14)(q25;q32) and found a fusion of the IgH gene and a LIM homeodomain gene.
Results

Clinical sample
A 53-year-old female was admitted to our hospital because of fever. She was diagnosed as having acute lymphoblastic leukemia of pre-B cell type. She was treated with multiple reagent chemotherapy. A complete remission was achieved after induction therapy, and consolidation and maintenance therapy were performed. During the maintenance therapy, the patient was transferred to another hospital to be treated by allogeneic bone marrow transplantation.
Q-banded karyotyping of her leukemic cells were performed as previously reported (Sandberg, 1990) . The karyotyping of her leukemic cells at admission revealed t(9;22)(q23;q11) and t(1;14)(q25;q32) ( Figure  1a ). After complete remission, these chromosomal abnormalities disappeared. Thus, she was diagnosed with de novo ALL, not blastic crisis from chronic myelogenous leukemia.
T(1;14)(q25;q32) was detected in acute lymphoblastic leukemia of pre-B cell type. We employed inverse PCR for the DNA from the leukemic cells. We obtained several bands (Figure 1b ) then we cloned the products into plasmids and sequenced them. Two bands revealed a novel sequence fused to the IgH gene (Figure 2 ). The breakpoint resided in the JH4 region of the IgH gene (Ravetch et al., 1981) . To exclude artifacts during the inverse PCR procedure, we performed a genomic PCR using one primer specific to IgH (JH4AS) and one novel sequence (WR1). PCR products were obtained from the leukemic cells but not from control DNA (Figure 3a) . The sequence of the PCR product was confirmed (data not shown). Further, we performed Southern blot analysis using one probe specific to IgH and a novel sequence (w360 probe). Using the IgH probe, two rearranged bands were detected on HindIII digestion and one rearranged band on EcoRI digestion, and using the w360 probe, a single rearranged band was detected in the EcoRI and HindIII digest, respectively (Figure 3b ). On HindIII digestion, one of the two rearranged bands detected by the IgH probe and the rearranged band detected by the W360 probe co-migrated (asterisks in Figure 3b ). On EcoRI digestion, the rearranged band detected by the w360 probe co-migrated with the germ line band detected by the IgH probe. This result might suggest that one of the rearranged bands detected by the IgH probe comigrated with the germ line band on EcoRI digestion, and that the rearranged bands detected by the IgH and w360 probes also co-migrated on EcoRI digestion.
Then we screened the phage genomic library using the w360 probe and obtained overlapping clones (Figure 4 ). Using one of the phage clones (lambda 1212) as a probe, we performed FISH to analyse the chromosomal localization of the novel sequence. The signals were detected at 1q23-25 (Figure 5a ). These results confirmed that the junctional sequence we cloned is derived from t(1;14)(q25;q32). Further, we detected fusion signals between the IgH gene and the novel sequence in these leukemic cells by the dual color FISH analysis (Figure 5b ) (see below).
We determined the genomic sequence around the breakpoint in the novel sequence and compared it with the rearranged sequence. The N-segment of 24 nucleotides was inserted between JH4 and the novel sequences ( Figure 2 ). Further, we sequenced the phage clones and searched for a gene around the breakpoint. We found a sequence highly homologous to mouse Lhx4 gene clones about 25 kb from the break point (Figure 4) .
To obtain the coding sequence of this putative gene, we performed anchor PCR on HEK293 cells. Then, we assembled the sequences and obtained a 1243-nucleotide cDNA sequence which had a single open reading frame of 1170 nucleotides (Figure 6a ). The deduced amino-acid sequence was highly homologous to that of mouse Lhx4 (Figure 6b ), so we concluded that this gene is a human homolog for mouse Lhx4 and named it the human Lhx4 gene. After our submission of this manuscript, two other groups have reported the cDNA sequence of the human Lhx4 gene (Liu et al., 2002; Machinis et al., 2001) . In the sequence reported by Machinis et al. (2001) the nucleotide sequence encoding N-terminal region is missing. The cDNA sequence of the human Lhx4 gene reported by Liu et al. (2002) is the same as that reported in this study.
The human Lhx4 gene encodes a product of 390 amino-acids, which is homologous to the Lhx family proteins (Dawid et al., 1998) . There is one tandem pair of LIM domains and one homeodomain, both of which Lhx4 is homologous to human Lhx3. However, the Nterminal sequence is completely different (Figure 6b ). Two isoforms (Lhx3A and Lhx3B) of human Lhx3 have been reported, in which the N-terminal regions are completely different (Sloop et al., 1999) . The transcriptional activity of these two proteins is different; Lhx3A induces expression of a reporter gene carrying the promoter region of the aGSU gene, which had a Lhx3 binding sequence. In contrast to Lhx3A, Lhx3B can not induce expression of the reporter gene (Sloop et al., 1999) . These results suggested that the Nterminal sequence of Lhx3 and Lhx4 might influence the functions of these proteins, especially transcriptional activity.
Comparing the human Lhx4 cDNA sequence with genomic sequences of the phage clones and genomic sequences from the human genome project data base, we found that the human Lhx4 gene consists of six exons (Figure 4 and 6c) and all exon-intron boundaries are compatible with the GT-AG exonintron boundary rule (Breathnach and Chambon, 1981) . In this translocation, the enhancer region of the IgH gene is fused to the 5' regulatory region of the Lhx4 gene in a head-to-head configuration. The exon encoding the initiation site of the Lhx4 resides about 17 kb from the breakpoint (Figure 4 ). Further, we performed two color FISH on the leukemic cells using the IgH gene and the PAC clone containing the Lhx4 gene as probes. We found fusion signals between the IgH and Lhx4 genes in most of the leukemic cells carrying t(1;14)(q25;q32) (97%) ( Figure  5b ).
We found the Lhx4 gene to be expressed in HEK293 cells. In mouse, it is reported that Lhx4 is important for organogenesis of pituitary. We used the human cell line, HP75, established from human (Jin et al., 1998) , for Northern blot analysis and detected the transcript to be about 4.3 kb long (Figure 7a ). To analyse the expression pattern of the Lhx4 gene in normal tissues, we performed Northern blotting and found no expression in any adult tissue examined (Figure 7b ). We detected expression of the Lhx4 gene in the original case with t(1;14)(q25;q32) by RT -PCR (Figure 7c ). Then, we performed Western blot analysis to confirm the protein expression of Lhx4 in leukemic cells. The size of the protein was 47 kDa and leukemic cells carrying t(1;14)(q25;q32) expressed Lhx4 (Figure 7d) . Recently, Sloop et al. (2001) have reported that a functional alternate translation form are generated from Lhx3 transcripts even in transfection analysis using the fulllength Lhx3 cDNA expression vector. In our experiments, we could not detect an alternate translation form of Lhx4.
These results suggested that the rearrangement of the IgH and Lhx4 genes led to the deregulation of the Lhx4 gene and expression of the transcript and protein of Lhx4 in the leukemic cells.
Further, we performed a reporter gene assay to define the transcriptional activity of Lhx4. Lhx4 has a homeodomain identical to that of the human Lhx3, so we used the aGSU reporter gene which is controlled by Lhx3 (Bach et al., 1995) . As a positive control, we transfected the Lhx3A gene, resulting in induction of reporter gene expression (Figure 8 upper) . Lhx4 also strongly induced expression of the reporter gene (Figure 8 lower) . Nuclear LIM interactor (NLI) (Jurata et al., 1996) , also called Ldb (LIM-domain binding) (Agulnick et al., 1996) or CLIM (cofactor of LIM homeodomain protein) (Bach et al., 1997) , binds the LIM domains of LIM homeodomian proteins and influences their transcriptional activity (Agulnick et al., 1996; Bach et al., 1997; Jurata et al., 1996) . Cotransfection of the NLI genes with the Lhx3A or Lhx4 gene decreased the induction of expression of the reporter genes (Figure 8 ). 
Discussion
We found a rearrangement of the IgH and Lhx4 genes, in which the 5' regulatory region of the Lhx4 gene was replaced by the enhancer region of the IgH gene. This could lead to the overexpression of the Lhx4 gene in leukemic cells. Lhx4 has a homeodomain which is one of the DNA binding domains and binds to a specific DNA sequence (Buske and Humphries, 2000) . Genes encoding proteins having homeodomains are called homeobox genes, and include Hox and Pbx genes. These genes play important roles in organogenesis and morphorogenesis (Buske and Humphries, 2000; Tenen et al., 1997) . Additionally, some homeobox proteins function in the normal differentiation and proliferation of hematopoietic cells (Buske and Humphries, 2000; Tenen et al., 1997) . Chromosomal translocations in leukemias involve several homeobox genes (Buske and Humphries, 2000; Look, 1997) . In T cell ALL with t(10;14)(q24;q11), the Hox11 gene (10q24) is translocated to the TCR gene (14q11), resulting in overexpression of Hox11. Pbx, which is frequently involved in E2A-Pbx rearrangement of pre-B ALL with t(1;19)(q23; p13), is also one of the homeodomain proteins. The MLL gene, which is involved in 11q23 translocations and has many translocation partner genes, also encodes a homeodomain protein. Alteration of these homeodomain protein genes influences the normal development of hematopoietic cells and could lead to leukemogenesis.
LIM homeodomain proteins differ from other homeobox proteins in several structural features (Dawid et al., 1998) . They have one tandem pair of LIM domains and one homeodomain, and are also transcriptional factors for neurogenesis (Sharma et al., 1998; Sheng et al., 1997; Thor et al., 1999) . The LIM domain is a cysteine-rich sequence recognized in the three homeobox gene products, Lin-1, Iyl-1, and Mec-3 (Dawid et al., 1998; Dawid and Chitnis, 2001; Freyd et al., 1990) . The LIM domains contributes to protein - protein interaction and is bound by NLI/CLIM2/Ldb1, leading to an increase in the transcriptional activity of LIM homeodomain proteins (Agulnick et al., 1996; Bach et al., 1997; Jurata et al., 1996) . However, in our system, co-transfection of NLI with Lhx4 or Lhx3A suppressed the transcriptional activity of Lhx4 or Lhx3A. Some feature of the cell line, A549, we used might cause this difference in the function of NLI. Nevertheless, the Lhx4 gene is deregulated in leukemic cells and the Lhx4 protein may play an important role, possibly as an activator, in leukemogenesis. LMOs, including LMO1 (Rhombotin 1, ttg1) and LMO2 (Rhombotin 2, ttg2), also members of the LIM family, were cloned from translocations of t(11;14)(p15;q11) and t(11;14)(p13;q11) of T-cell ALL. Although LMOs have one tandem pair of LIM domains, they lack a homeodomain and do not directly bind to DNA (Rabbitts, 1998) . A complex of LMO, SCL and GATA1 proteins is detected in premature erythroid cells. Mice deficient in LMO1 cannot generate hematopoiesis, which suggests that LMOs contribute to hematopoiesis (Rabbitts, 1998) . LMO transgenic mice develop leukemia after a long period, which suggests that the overexpression of LMOs is not enough for leukemogenesis and a 'second hit' promotes the development of leukemia in these mice (Rabbitts, 1998) . The structure of the tandem pair of LIM domains in LMOs and in Lhx4 are homologous. The LIM domains of Lhx4 might also function as LMOs and be associated with cellular transformation in B-cell lineage ALL.
Some of the target genes of Lhx3, which is very homologous to Lhx4, were pituitary hormone genes (Bach et al., 1995) . However, no target genes for proliferation or anti-apoptosis have been reported for Lhx proteins. In organogenesis, it is not clear which genes are the target of Lhx4. Mice deficient in Lhx4 had an impaired respiratory function and died (Li et al., 1994) . Because of this early death, no study was performed on the function of the lymphocytes of these mice. Recently, Machinis et al. (2001) have reported mutations of the human Lhx4 gene which cause the short stature syndrome. They speculated that the mutations of the Lhx4 gene lead the defect of pituitary and lack of hormones, including growth hormone, which could result in the cause of short stature (Machinis et al., 2001) . There is no report about the impairment of hematopoiesis in Lhx4-deficient mice and human (Li et al., 1994; Machinis et al., 2001) . The exact function of Lhx4 in hematopoiesis remains to be disclosed. At present, it is unclear how Lhx4 is associated with leukemogenesis. We performed a cellular transformation assay using rat fibroblast (Rat1) and mouse fibroblast (NIH3T3) cells, however we could not define the transformation activity in the Lhx4 gene (Sakajiri et al. unpublished data) . The functions of Lhx4 in tumorigenesis might not be defined by these systems. Recently, Liu et al. (2002) reported the Lhx4 are predominantly expressed in fetal and adult central nervous system. Adult neuronal cells do not usually proliferate rapidly. So, overexpression of Lhx4 might be associated with anti-apoptosis rather than cellular proliferation. Nevertheless, identifying the target genes controlled by Lhx4 could be a key to elucidating the contribution of Lhx4 to leukemogenesis.
We screened for the rearrangements of 10 cases with pre B ALL using the w360 probe and found none (Sakajiri et al. unpublished data) . IgH/Lhx4 rearrangements might be rare in ALL, or the breakpoints might exist outside the regions detected using the w360 probe. Unfortunately, we could not perform FISH analysis and RT -PCR on these clinical samples. We examined the levels of Lhx4 in human leukemic and cancer cell lines by RT -PCR and found expression in HEK293 (embryonic kidney) and SY5Y (neuroblastoma) cell lines (data not shown). Recently, overexpression of Lhx2 has been reported in chronic myelogenous leukemias and acute lymphoblastic leukemias (Wu et al., 1996; Wu and Minden, 1997) . Demethylation of the promoter region of the Lhx2 gene could be associated with deregulation of this gene. Although no functional contribution of Lhx2 to leukemogenesis was reported, Lhx family proteins might play important roles in the cellular transformation of B-lymphocytes.
Materials and methods
DNA extraction and Southern blotting
Genomic DNA was extracted from the leukemic cells by the standard phenol-chloroform method as previously described (Sambrook and Russell, 2001 ) with informed consent. The DNA was digested with restriction enzymes, EcoRI or HindIII (Takara, Kyoto, Japan), and electrophoresed in 0.8% agarose gel containing Tris acetate EDTA (TAE) buffer. It was then transferred to nylon membrane (Hybond N+, Amershampharmacia, Uppsala, Sweden) as recommended by the manufacturer. The membrane was hybridized with radiolabeled DNA probes. A probe specific to the JH region of the immunoglobulin gene (Miki et al., 1994) , and the w360 probe specific to the 1q25 region was generated by PCR using a pair of primers, W1:CAG GCC GGA GTC CAG TAG TA and WR1:GCA CTT TAG GGA GCT TTG AG, from normal human DNA. The PCR products were ligated into pGEM-T vector (Promega, Madison, WI, USA) and the nucleotide sequence was confirmed.
The radio-labeled probes were generated using a Ready-togo DNA labeling kit and 32 P-dCTP (Amershampharmacia) according to the manufacturer's protocols. Pre-hybridization, hybridization and washing were performed as recommended by the manufacturer. The membranes were exposed to imaging plates and analysed by an imaging analyser BAS 2500 (Fuji Film, Tokyo, Japan).
RNA extraction, Northern blotting and reverse transcription PCR (RT -PCR)
Total RNA from clinical samples and cell lines was extracted using Isogen solution (Nippon gene, Tokyo, Japan). A human pituitary adenoma cell line, HP75 was provided from Dr RV Lloyd (Jin et al., 1998) . Human leukemic cell lines, HL60 (myeloid), U937 (monocyte), K562 (erythroid), Jurkat (T-cell), Daudi, Raji (B-cell), HEK293 (embryoic kidney), A549 (Lung cancer), MCF7 (breast cancer) and SY5Y
IgH/Lhx4 rearrangement in pre-B ALL N Kawamata et al (neuroblastoma) were provided from American Type Culture Collection (Manassas, VA, USA). Aliquots (20 mg) of the RNA were electrophoresed in 1% agarose gel containing 2.2 M formaldehyde as previously described (Sambrook and Russell, 2001) . They were then transferred to nylon membrane (Hybond N+) according to the instruction manual. A multiple tissue blot was purchased from Clontech (Palo Alto, CA, USA). Pre-hybridization, hybridization and washing were performed as recommended by the manufacturer. The coding region of the human Lhx4 gene was used for the radio-labeled probe. As an internal control, the beta 2 microglobulin (b2MG) gene was radio-labeled. The signals were exposed to imaging plates and analysed by the BAS2500 (Fuji Film).
RT -PCR was performed with the total RNA using Ready-To-Go RT -PCR beads (Amershampharmacia) according to the manufacturer's protocol. For detection of the Lhx4 transcripts, we used as primers, Det-Lhx4S: GGG AGC GTC TAC TGC AAG G and Det-Lhx4AS: GCT TAG CTC CAG CCT CTG A. As an internal control, we amplified the transcripts of the b2MG gene using, B2MG-S: ACC CCC ACT GAA AAA GAT GA and B2MG-R: ATC TTC AAA CCT CCA TGA TG. The PCR products were electrophoresed in 2% agarose gel containing TAE buffer, then stained with ethidium bromide and photographed under UV light.
Fluorescence in situ hybridization (FISH)
Phage and PAC DNAs were extracted as previously described (Sambrook and Russell, 2001) . DNA probes were labeled with biotin-14-dATP (Gibco BRL, Rockville, MD, USA) and hybridized to metaphase spreads from normal human lymphocytes as previously described (Kobayashi et al., 1994) . Hybridization signals and the corresponding chromosomal bands were visualized with fluorescein isothiocyanate (FITC)-conjugated avidin (Oncor, Gaitherburg, MD, USA) after staining with 4',6-diamidino-2-phenylindole dihydrochloride.
To confirm the rearrangements between the IgH and Lhx4 genes, we performed two color FISH as previously reported (Kobayashi et al., 1994) . The DNA extracted from the PAC clone containing the Lhx4 gene was labeled with rhodamine. The probes for IgH were labeled with FITC. The signals were detected by fluorescence microscopy and photographed.
Inverse PCR, genomic PCR and anchor PCR Inverse PCR was performed according to the protocol reported by Willis et al. (1997) . Briefly, high molecular weight DNAs were digested with restriction enzymes (BglII or XbaI ), then 0.4 micrograms of the digested DNAs were purified and ligated at 158C overnight to generate circular DNAs. The self-ligated circular DNAs were purified and subjected to PCR. For BglII-digested DNAs, the first round of PCR was performed using the primers, JBE: GAA GCA GGT CAC CGC GAG AGT and J6E: CCC ACA GGC AGT AGC AGA AAA CAA. The second round of nested PCR was performed using JBI: CTT CTG GTT GTG AAG AGG TGG TTT TG and J6I: TCT GGG CTC GAG TCG ACG CAG AAA ACA AAG GCC CTA GAG GG. For XbaI-digested DNAs, the first-round PCR was performed using JXE: CAC TGG CAT CGC CCT TTG TCT AA and J6E. The second round of nested PCR was performed using JXI: CCC ATG CCT TCC AAA GCG ATT and J6I.
The amplified PCR bands were cut out from the agarose gels and purified. After ligation into pGEM-3Zf(+) vectors (Promega), the PCR products were sequenced on a Genetic analyzer 310 (Applied biosystems, Foster City, CA, USA).
To confirm the fusion sequence, we performed PCR using the JH-specific primer JH4-AS:GCA GGA GAG AGG TTG TGA GG and the WR1 primer, on DNA extracted from the leukemic sample carrying t(1;14) and or a Tcell line, Jurkat, as a control.
To obtain the full length of the human Lhx4 cDNA sequence, we performed anchor PCR on RNA extracted from human embryonic kidney (HEK) 293 cells using the Marathon cDNA amplification kit (Clontech) according to the manufacturer's protocol. The sequences were assembled and a single open reading frame was identified.
Genomic library screening
A Lambda phage genomic library was obtained from Health Science Research Resources Bank (Tokyo, Japan). The library was screened using the w360 probe as previously described (Sambrook and Russell, 2001 ). A PAC library was obtained from Research Genetics (Huntsville, AL, USA) and screened by PCR using as primers, Lhx4-HD-S: CAA GAA CTC CCC CAA GCC TG and Lhx4-BoAS: GGA AGC TCA GCT CAC TGT C, according to manufacturer's recommendations. Then a PAC clone, RP5-1180C10, which contained the human Lhx4 gene, was obtained from Research Genetics.
Reporter gene assay
For the mouse a-glycoprotein subunit (aGSU) reporter gene, the fragment, 7440 to +1, containing the promoter region was amplified by PCR using as primers, MaGSU-S: TTT GGT ACC TTT ATT AAA TCC AGA GCC TG, and MaGSU-AS: TTT CTC GAG TGC CTG CAG TTA ATA AAG TCT (underlined sequences are additional sequences of KpnI and XhoI sites designed for subcloning) and ligated into pGL3 basic vector (Promega) (Bach et al., 1995) . The sequence of the ligated fragment was determined. Internal control vector, pRL was purchased from Promega. The fulllength coding region of the Lhx4 gene was ligated into pcDNA3.1(+) vector (Invitrogen, Groningen, The Netherlands). The NLI expression vector was provided by Dr GN Gill, and the Lhx3A and Lhx3B expression vectors were provided by Dr SJ Rhodes. The mixtures of DNA were transfected into the A549 human lung cancer cell line using Effecten Transfection Reagent (Quagen, Hilden, Germany) according to the manufacturer's instructions. We used 6-well plates for transfection, and seeded 1610 5 cells per well 1 day before transfection. The cells were transfected with 0.1 mg of pRL vector, 1 mg of pGL-aGSU or pGL3 vector, 1 mg of Lhx4 or Lhx3 or empty vector, and 1 mg of NLI or empty vector. The experiments were triplicated. The luciferase activity was measured using a Dual-luciferase reporter assay kit (Promega) on a luminometer, Lumat LB9507 (Berthold, Bad Wildbad, Germany). The activity was calibrated with activity of internal control Renilla luciferases translated from pRL vectors. Results are expressed as fold-activation compared to the activity of the aGSU promoter in the presence of an empty vector.
Western blot analysis
Western blot analysis was performed using an antibody specific to mouse Lhx4 proteins provided by Dr SL Pfaff. For an internal control, we used anti-beta-actin antibody (Sigma, St. Louis, MI, USA). As positive and negative controls for Lhx4 protein expression, we transfected the Lhx4 expression and empty vectors into the A549 cell line, which does not endogenously express Lhx4 mRNA. Cells were lysed with RIPA lysis buffer (1% Triton X-100, 20 mM Tris-HCl, pH 7.5, 10% glycerol, 140 mM NaCl, 100 mM sodium fluoride, 10 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 0.5% sodium deoxycholate, 0.1% SDS) and proteins were electrophoresed in SDS-polyacrylamide gel using standard methods (Sambrook and Russell, 2001 ). Fractionated proteins were transferred onto nitrocellulose filters, Hybond ECL (Amershampharmacia). The secondary horse radish peroxidase-conjugated anti-rabbit or anti-mouse immunoglobulin antibody was purchased from New England Biolab (Beverly, MA, USA). Blocking, the reaction and washing were performed according to the manufacturer's recommendations. The signals were detected using Supersignal West Pico chemiluminescent substrate (Pierce, Rockford, IL, USA). The signals were exposed to X-ray films according to the manufacturer's instructions.
